Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to $6.6 million.

  • Marimed's Cash & Current Investments fell 3261.14% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 3261.14%. This contributed to the annual value of $7.3 million for FY2024, which is 5057.35% down from last year.
  • According to the latest figures from Q3 2025, Marimed's Cash & Current Investments is $6.6 million, which was down 3261.14% from $6.1 million recorded in Q2 2025.
  • Marimed's Cash & Current Investments' 5-year high stood at $34.7 million during Q1 2022, with a 5-year trough of $6.1 million in Q2 2025.
  • Over the past 5 years, Marimed's median Cash & Current Investments value was $13.4 million (recorded in 2023), while the average stood at $14.7 million.
  • As far as peak fluctuations go, Marimed's Cash & Current Investments skyrocketed by 69658.16% in 2021, and later plummeted by 6706.09% in 2022.
  • Quarter analysis of 5 years shows Marimed's Cash & Current Investments stood at $29.9 million in 2021, then crashed by 67.06% to $9.9 million in 2022, then soared by 49.42% to $14.7 million in 2023, then plummeted by 50.57% to $7.3 million in 2024, then fell by 9.42% to $6.6 million in 2025.
  • Its Cash & Current Investments stands at $6.6 million for Q3 2025, versus $6.1 million for Q2 2025 and $7.2 million for Q1 2025.